ask="2.21"
ask_size="200"
average_daily_volume="101717"
bid="N/A"
bid_size="N/A"
book_value="1.40"
change="-0.18"
change_from_200_day_moving_average="1.02"
change_from_50_day_moving_average="0.54"
change_from_52_week_high="-5.84"
change_From_52_week_low="0.07"
change_in_percent="-8.23%"
close="2.01"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-2.11M"
eps_estimate_current_year="-0.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.02"
ex_dividend_date="N/A"
float_shares="2160000"
high="2.22"
high_52_weeks="7.85"
last_trade_date="3/6/2017"
last_trade_price="2.01"
last_trade_size="124"
last_trade_time="4:00pm"
low="1.96"
low_52_weeks="1.94"
market_capitalization="5.39M"
moving_average_200_day="0.99"
moving_average_50_day="1.47"
name="XTL Biopharmaceuticals Ltd."
notes="N/A"
one_year_target_price="30.00"
open="2.17"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+102.23%"
percent_change_from_50_day_moving_average="+36.46%"
percent_change_from_52_week_high="-74.39%"
percent_change_from_52_week_low="+3.50%"
previous_close="2.19"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.56"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="2680000"
short_ratio="0.30"
stock_exchange="NCM"
symbol="XTLB"
volume="117716"
weeks_range_52="1.94 - 7.85"
